Quart Barry D — SEC Form 4 filings
SEC reporting owner CIK 1384243. 10 Form 4 filings on record with FilingPulse; latest filed 2026-08-21.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-06-07 to 2026-08-21. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 11 legs across 6 filings — 86,337 shares, $3,517,501 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 35.
- Largest priced transaction: sale of 20,129 shares @ $41.51 ($835,555) in Kiniksa Pharmaceuticals International, plc, filed 2025-12-17.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Kiniksa Pharmaceuticals International, plc (KNSA) | Director | 10 | — | 11 legs · 86,337 sh · $3,517,501 | 35 |
Form 4 filings — Quart Barry D
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-21 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Gift (G): 2,600 @ $0 | EDGAR |
| 2026-06-02 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 2,799 · Grant/award (A): 12,158 (derivative) @ $0 · Grant/award (A): 2,026 (derivative) @ $0 · Option exercise (M): 2,799 (derivative) @ $0 | EDGAR |
| 2026-04-29 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 13,099 @ $14.33 · Sale (S): 13,099 @ $50.10 · Option exercise (M): 13,099 (derivative) @ $0 | EDGAR |
| 2026-04-08 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 6,901 @ $14.33 · Sale (S): 6,901 @ $50 · Option exercise (M): 6,901 (derivative) @ $0 | EDGAR |
| 2026-02-12 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 110 @ $15.47 · Sale (S): 110 @ $45 · Option exercise (M): 2,690 @ $15.47 · Sale (S): 2,690 @ $45 · Option exercise (M): 110 (derivative) @ $0 · Option exercise (M): 2,690 (derivative) @ $0 | EDGAR |
| 2026-02-04 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 830 @ $15.47 · Sale (S): 830 @ $45 · Option exercise (M): 12,528 @ $15.47 · Sale (S): 12,528 @ $45.27 · Option exercise (M): 2,602 @ $15.47 · Sale (S): 2,602 @ $45.02 · +3 more | EDGAR |
| 2025-12-17 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 20,129 @ $10.36 · Sale (S): 20,129 @ $41.51 · Option exercise (M): 20,129 (derivative) @ $0 | EDGAR |
| 2025-06-11 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 6,900 @ $3.80 · Sale (S): 6,900 @ $30.26 · Option exercise (M): 8,212 @ $3.80 · Sale (S): 8,212 @ $30.36 · Option exercise (M): 12,336 @ $3.80 · Sale (S): 12,336 @ $30.39 · +3 more | EDGAR |
| 2025-06-05 | 4 | Kiniksa Pharmaceuticals International, plc (KNSA) | Option exercise (M): 3,173 · Grant/award (A): 16,798 (derivative) @ $0 · Grant/award (A): 2,799 (derivative) @ $0 · Option exercise (M): 3,173 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | Kiniksa Pharmaceuticals, Ltd. (KNSA) | Option exercise (M): 4,373 · Grant/award (A): 19,040 (derivative) @ $0 · Grant/award (A): 3,173 (derivative) @ $0 · Option exercise (M): 4,373 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1384243 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →